Karuna Therapeutics(KRTX) - 2020 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR Delaware 27-0605902 (State or other jurisdiction of incorporation or organization) 33 Arch Street, Suite 3110 Boston, Massachusetts 02110 (I.R.S. Employer Identification No.) (Address of principal executive offices) (Zip Code) Securities registered pursuant to Section 12(b) of the ...